HK1 and cancer: 3-Bromopyruvate acid (3BrPA) is another classic glycolytic inhibitor, which inhibits several enzymes in the glycolytic pathway, including HK and LDH, and is a potent inhibitor of cancer cell growth [52,53,54,55].